These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37404789)

  • 21. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.
    Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis.
    Liu Y; Zhu J; Chen M; Wang L; Zhu M; Weng Z; Hu C
    Ann Transl Med; 2022 Jul; 10(14):794. PubMed ID: 35965812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.
    Azuma M; Kato S; Sekii R; Kodama S; Kinoshita K; Suzurikawa K; Kagimoto M; Nakayama N; Iguchi K; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
    Int J Cardiovasc Imaging; 2021 Aug; 37(8):2535-2543. PubMed ID: 33725266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac MRI to Predict Sudden Cardiac Death Risk in Dilated Cardiomyopathy.
    Li Y; Xu Y; Li W; Guo J; Wan K; Wang J; Xu Z; Han Y; Sun J; Chen Y
    Radiology; 2023 May; 307(3):e222552. PubMed ID: 36916890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial Extracellular Volume Fraction Allows Differentiation of Reversible Versus Irreversible Myocardial Damage and Prediction of Adverse Left Ventricular Remodeling of ST-Elevation Myocardial Infarction.
    Chen BH; An DA; He J; Xu JR; Wu LM; Pu J
    J Magn Reson Imaging; 2020 Aug; 52(2):476-487. PubMed ID: 31943526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
    Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
    Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis.
    Minegishi S; Kato S; Takase-Minegishi K; Horita N; Azushima K; Wakui H; Ishigami T; Kosuge M; Kimura K; Tamura K
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100422. PubMed ID: 31517037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
    de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease.
    Pinheiro MVT; Moll-Bernardes RJ; Camargo GC; Siqueira FP; Azevedo CF; Holanda MT; Mendes FSNS; Sangenis LHC; Mediano MFF; Sousa AS
    Am J Trop Med Hyg; 2020 Aug; 103(2):745-751. PubMed ID: 32431281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
    Kellman P; Wilson JR; Xue H; Bandettini WP; Shanbhag SM; Druey KM; Ugander M; Arai AE
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):64. PubMed ID: 22967246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping.
    Gong C; Guo J; Wan K; Wang L; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen C; Chen Y
    J Cardiovasc Magn Reson; 2022 Nov; 24(1):60. PubMed ID: 36404313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy.
    Di Marco A; Brown PF; Bradley J; Nucifora G; Anguera I; Miller CA; Schmitt M
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):512-521. PubMed ID: 35877070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.